Members of the polo-like family of protein kinases have been involved in the control of APC (anaphasepromoting complex) during the cell cycle, yet how they activate APC is not understood in any detail. In Xenopus oocytes, Ca 2+ -dependent degradation of cyclin B associated with release from arrest at second meiotic metaphase was demonstrated to require the polo-like kinase Plx1. The aim of the present study was to examine, beyond Ca 2+ -dependent resumption of meiosis, the possible role of Plx1 in the control of cyclin degradation during the early mitotic cell cycle. Plx1 was found to be dispensable for MPF to turn on the cyclin degradation machinery. However, it is required to prevent premature inactivation of the APC-dependent proteolytic pathway. Microcystin suppresses the requirement for Plx1 in both Ca 2+ -dependent exit from meiosis, associated with degradation of both cyclin B and A downstream of CaMK2 activation, and prevention of premature APC Fizzy inactivation in the early mitotic cell cycle. These results are consistent with the view that Plx1 antagonizes an unidenti®ed microcystin-sensitive phosphatase that inactivates APC
Fizzy Introduction
The cell division cycle is a highly ordered and tightly regulated process whose main events are the duplication, then the segregation of duplicated chromosomes at anaphase. In yeast and possibly higher eukaryotes, the anaphase-promoting complex (APC) mediates onset of anaphase through proteolysis of securins, that associate with separins and prevent them from promoting chromatid separation (for review, see Zachariae and Nasmyth, 1999) . Besides sister chromatid separation, events like spindle elongation, migration of chromatids towards the spindle pole, and other events associated with exit from mitosis, including spindle disassembly, cytokinesis, chromosome decondensation and reassembly of functional interphase nuclei, might all be promoted by APC-dependent proteolysis. Consistent with this view, levels of several proteins potentially involved in the control of mitotic events¯uctuate during the cell cycle with kinetics consistent with degradation by the APC-dependent proteolytic pathway.
Activation of APC at mid-M phase depends, directly or indirectly (Felix et al., 1990a) , on cyclin B-cdc2 kinase activity, that triggers phosphorylation of APC subunits, a permissive event for APC to bind its activator cdc20/Fizzy (Kotani et al., 1999; Zachariae, 1999) . In both yeast (reviewed in Zachariae and Nasmyth, 1999) and somatic cells of higher eukaryotes (Brandeis and Hunt, 1996) , the APC-dependent proteolytic pathway keeps active from mid-M phase to late G1, at which time it is turned o. During this interval of time, APC switches from a mitoticallyphosphorylated form that uses cdc20/Fizzy to a dephosphorylated form that uses cdh1/Fizzy-related as activators respectively (Visintin et al., 1997; Schwab et al., 1997; Sigrist and Lehner, 1997; Fang et al., 1998; Kramer et al., 1998; Zachariae et al., 1998) .
During early development, Fizzy-related is not expressed, at least in Drosophila and Xenopus, and activity of APC seems to depend only on Fizzy (Sigrist and Lehner, 1997; Lorca et al., 1998) . This is expected to shorten the window of APC activity. Yet, embryonic cells must maintain a low level of MPF activity to complete mitosis and reassemble functional nuclei, in spite of sustained translation of mitotic cyclins. One way uses inhibitory phosphorylations on cdc2 to prevent premature MPF activation (Solomon et al., 1990) . Another theoretically possible way, as yet poorly explored, might possibly involve some mechanism preventing premature inactivation of the APC-dependent proteolytic pathway.
An okadaic acid/microcystin-sensitive phosphatase has been shown to negatively control the cyclin degradation pathway in eggs and early embryos of both vertebrates and invertebrates (Felix et al., 1990b; Lorca et al., 1991a; Lahav-Baratz et al., 1995) . Constitutive activity of this phosphatase is believed to turn o APC Fizzy activity when cyclin B-cdc2 kinase drops below a critical threshold activity. Depletion of the Polo-like kinase Plx1 has been shown recently to prevent Ca 2+ -dependent activation of the APC-dependent proteolytic pathway in extracts prepared from unfertilized Xenopus eggs (Descombes and Nigg, 1998) . Moreover, the human Polo-like kinase Plk1 phosphorylates several APC core subunits in vitro and this stimulates the cyclin B ubiquitination pathway (Kotani et al., 1998) . In the present study, we show that suppression of Plx1 activity causes premature inactivation of APC-dependent proteolysis in the early mitotic cell cycle in the absence but not the presence of microcystin. Thus Plx1 may be a component of a mechanism that antagonizes an okadaic acid/micro-cystin-sensitive phosphatase and allows late APCdependent degradation of cyclins and other substrates of the ubiquitin-proteasome pathway at exit from mitosis in the early embryonic cell cycle.
Results
Plx1 delays the time of APC/proteasome inactivation associated with the drop of cyclin B-cdc2 kinase Plx1 has been shown to be required for extracts prepared from metaphase II-arrested Xenopus oocytes to degrade cyclin B and inactivate MPF following activation by Ca 2+ (Descombes and Nigg, 1998) . This event is relayed by a well known mechanism through CaMK II activation (Lorca et al., 1991b (Lorca et al., , 1993 . The question as to whether it is also required for activation of the APC/proteasome pathway in the regular mitotic cell cycle has not been answered previously. This is because Plx1 has pleiotropic eects on cell cycle progression, that make it dicult to unambiguously answer this question.
We observed that suppression of Plx1 activity prevents activation of the APC Fizzy -dependent proteolytic pathway in cycling egg extracts (our unpublished results). However, Plx1 is absolutely required for cyclin B-cdc2 kinase activation in such extracts, although it is dispensable for cyclin A-cdc2 kinase activation (Abrieu et al., 1998) . As cyclin B-cdc2 kinase eciently activates the APC Fizzy -dependent proteolytic pathway, and cyclin A-cdc2 kinase does not (Luca et al., 1991; Lorca et al., 1992) , suppression of cyclin degradation in extracts deleted of Plx1 activity could have been the mere consequence of suppressing cyclin B-cdc2 kinase activation. Then to circumvent this particular relationship between Plx1 and APC Fizzy function by the way of cyclin B-cdc2 kinase activation, we used an already active cyclin Bcdc2 kinase, puri®ed to apparent homogeneity from star®sh oocytes (LabbeÂ et al., 1989) .
Star®sh cyclin cyclin B was added to cell cycle extracts prepared at ®rst interphase and containing the same amount of either the dominant negative Plx1 (N172A) mutant or the wild-type Plx1 (Descombes and Nigg, 1998) . Then the kinetics of star®sh cyclin B degradation was monitored by Western blotting as a function of time. As shown in Figure 1a , cyclin B degradation ®rst proceeded rapidly in both cases. After 15 ± 35 min however, the rate of cyclin B degradation dropped in extracts containing the Plx1 dominantnegative mutant, whilst cyclin B degradation continued to proceed rapidly in extracts containing wild-type Plx1. Two hours after addition of star®sh kinase, cyclin B was still detected in the ®rst case, whilst it had almost completely disappeared from extracts as early as 1 h earlier in the second case. Since phosphorylation gel-shift of cdc27 is known as a landmark of APC Fizzy -dependent cyclin B degradation, we monitored in the same experiments its phosphorylation status. As shown in Figure 1b , dephosphorylation of cdc27 paralleled cyclin B degradation.
This experiment suggested that, although not required for its activation, Plx1 activity prevented premature slowing-down or inactivation of the APCFizzy -dependent proteolytic pathway. This experiment was repeated several times with egg extracts prepared from dierent females, and in all cases similar results were obtained (Table 1) .
To obtain independent evidence that Plx1 kinase activity is required to prevent premature inactivation of the APC Fizzy -proteasome pathway, kinetics of cyclin B degradation were compared in extracts immunodepleted or not of Plx1. Plx1 activity strongly increased upon addition of star®sh cyclin B-cdc2 kinase to control (non serum-treated) and mock-depleted extracts ( Figure 2a , panels 1 and 2 respectively), an expected result in view of the reported positive feed- Figure 1 The dominant-negative Plx1 (N172A) mutant slows-down prematurely the rate of cyclin B degradation triggered by addition of star®sh cyclin B-cdc2 kinase to interphase egg extracts. Star®sh cyclin B-cdc2 kinase (®nal speci®c activity: about 20 picomoles phosphate transferred to H1 histones/min/ml extract) was added at zero time to an interphase extract containing either the recombinant Plx1 (N172A) mutant or the same amount of its wild-type counterpart. Aliquots were taken at the indicated times and analysed by Western blotting for residual star®sh cyclin B content (a) or electrophoretic mobility of the APC subunit cdc27 (b) back loop between plx1 and cyclin-B-cdc2 kinase (reviewed in Nigg, 1998) . In contrast it did not increase in extracts depleted of Plx1 ( Figure 2a , panel 3). As shown in Figure 2b , degradation of cyclin B occurred with dierent kinetics in either cases: whilst cyclin B had almost completely disappeared from control extracts after 60 min (panels 1 and 2), as much as about one-third of the initial cyclin B was still detected at the same time in extracts depleted of Plx1 activity ( Figure 2b, panel 3) .
The above results show that initial degradation of cyclin B proceeds rapidly in the nearly complete absence of Plx1 activity, and that Plx1 is required to maintain a high level of APC activity. The fact that a high Plx1 kinase activity is still detected after complete proteolysis of cyclin B in egg extracts, and that it declines later than the decline in H1 kinase activity at each cell cycle in the early Xenopus embryo (Qian et al., 1998) , is consistent with this view.
Plx1 antagonizes a microcystin-sensitive phosphatase that inactivates the APC Fizzy -dependent proteolytic pathway
We previously reported (Lorca et al., 1991b ) that inhibition of phosphatases sensitive to okadaic acid and microcystin releases the cyclin degradation pathway from its inhibited state in CSF extracts prepared from unfertilized Xenopus eggs, arrested at the second meiotic metaphase. Moreover, both phosphatase inhibitors can switch on the cyclin degradation pathway in interphase extracts prepared from parthenogenetically-activated eggs (Lorca et al., 1991b) . This ®nding was used by others to purify the APC cyclosome in its active form (Lahav-Baratz et al., 1995) . On the other hand, suppression of Plx1 activity in CSF egg extracts blocks their Ca 2+ -induced release into interphase (Descombes and Nigg, 1998) . Concomitantly, the proteolytic destruction of several targets of APC is prevented.
We previously demonstrated that the Ca 2+ transient associated with fertilization ultimately activates the ubiquitin-dependent cyclin degradation pathway through activation of CaMK II (Lorca et al., 1993) . The initially localized Ca 2+ transient associated with fertilization propagates within the fertilized egg through a complex process of Ca
release involving the network of intracellular membranes (reviewed in Gilkey et al., 1978; Jae, 1991) . Although the requirement of Plx1 for Ca 2+ -dependent activation of APC in CSF extracts was assumed to be downstream of CaMK II activation, this was not formally demonstrated previously. As shown in Figure  3a ,b, we ®rst established this point by demonstrating that the dominant-negative Plx1 N172A suppresses induction of [ . We further extended to cyclin A the requirement of Plx1 for Ca 2+ -dependent degradation of cyclins in the same extracts (Figure 4) .
We reasoned that, if Plx1 antagonizes a microcystinsensitive phosphatase that inactivates proteolysis, it should not be required any more once phosphatase activity has been blocked by the phosphatase inhibitor. Experiments similar to those depicted in Figure 1 (experiments 1 and 2) and Figure 3 (experiment 3) were quanti®ed by optical scanning with NIH image 1.62 software to allow calculation from Western blots of interpolated times for 65% degradation of cyclin B Figure 2 Immunodepletion of Plx1 slows down prematurely the rate of cyclin B degradation triggered by addition of star®sh cyclin B-cdc2 kinase to interphase egg extracts. Star®sh cyclin B-cdc2 kinase was added at zero time to: (1): a non serum-treated interphase extract; (2): a control, mock-depleted interphase extract or (3): an interphase extract immunodepleted of Plx1. As a control for basal Plx1 activity, one aliquot was removed (lane ctrl) of the interphase extract before it was split in three aliquots for experiments 1, 2 and 3. Samples were taken at the indicated times, then either immunoprecipitated and assayed for Plx1 activity with a-casein as substrate (Figure 3a) or cyclin A degradation (Figure 4) following CaMK II addition (Lorca et al., 1993) . As shown in Figure 3h ,i, in such conditions Plx1 N172A did not cause any detectable change of cdc27 electrophoretic mobility. This suggested that the requirement of Plx1 activity for Ca 2+ -dependent degradation of mitotic cyclins in the absence of phosphatase inhibitor may not be ascribed only to its role in phosphorylation of this APC subunit.
We were concerned that the unphysiological use of a potent phosphatase inhibitor may have deregulated mechanisms controlling cyclin degradation in the above experiment. Recruitment of cdc20/Fizzy is believed to be an essential rate-limiting step in activation of APC at M phase (for review see Zachariae and Nasmyth, 1999) . As shown in Figure 3f , antibodies directed against its Xenopus homolog, X-FZY, readily suppressed microcystin-dependent degradation of cyclin B1, con®rming previous results (Chen et al., 1996; Lorca et al., 1998) , and demonstrating that APC activation remains dependent on X-FZY in the presence of microcystin. In the same way, Figure 3g shows that microcystin-dependent activation of cyclin degradation in egg extracts can be suppressed by prior addition of the recombinant spindle checkpoint MAD2 protein (Lorca et al., 1998) .
The above results are consistent with the view that a phosphatase sensitive to microcystin antagonizes Plx1 in CSF extracts: if the activity of this phosphatase is suppressed, the requirement of Plx1 for Ca 2+ -dependent activation of the APC Fizzy -proteasome pathway is abolished.
As the regular mitotic cell cycle is not believed to require Ca 2+ for activation of the cyclin degradation pathway, the antagonism between Plx1 and the unidenti®ed microcystin sensitive phosphatase could be restricted to conditions prevailing in CSF extracts. To examine this possibility, we used interphase extracts prepared 40 min after parthenogenetic activation of unfertilized Xenopus eggs. These extracts do not contain signi®cant Plx1 activity. Eggs taken at that time contain pre-MPF, that frequently activates spontaneously in 40 min extracts, and this occurs systematically in the presence of okadaic acid or microcystin, resulting in activation of the cyclin degradation pathway (Felix et al., 1990b) . We reported previously that the cyclin degradation pathway is turned on for only one round in the absence of phospatase inhibitor, and inactivates when endogenous cyclins A and B have been destroyed. In the presence of okadaic acid or microcystin in contrast, the cyclin degradation machinery remains switched on in a permanent fashion (Lorca et al., 1991a) .
In the next experiment, activity of the cyclin degradation machinery was monitored by adding To monitor the plx1-dependent event in cyclin B degradation, Plx1 (N172A) mutant recombinant protein was added to the aliquots of CSF extracts 5 min before CaMK II (a) or microcystin (c). The suppression of microcystin-induced degradation of cyclin B was monitored by adding either an inactivating antibody directed against Fizzy (aX-FZY: f) or the recombinant Mad2 checkpoint protein (g) 5 min before microcystin addition. Changes of cdc27 electrophoretic mobility were monitored by Western blotting in samples taken at the indicated times from extracts treated with constitutively active CaMK II in the presence of the dominant negative Plx1 (N172A) mutant (h) or its wildtype counterpart (i) Figure 4 The dominant negative Plx1 (N172A) mutant suppresses CaMK II -induced degradation of cyclin A in CSF extracts. Recombinant human cyclin A was added at zero time, simultaneously with CaMK II , in a CSF extract containing either the Plx1 (N172A) mutant or its wild-type counterpart. Degradation of cyclin A was monitored by Western blotting as a function of time elapsed from CaMK II addition [ 35 S]cyclin B at various times after the addition of microcystin in 40 min extracts containing either an antibody preventing Plx1 activation (Abrieu et al., 1998;  Figure 5c lanes b and c) or the same amount of unrelated, control immunoglobulins ( Figure 5c lanes d  and e) . As a control, Plx1 activity was monitored before addition of microcystin to the extract (Figure 5c  lane a) . As expected, microcystin switched on the cyclin degradation pathway in a permanent fashion in control extracts (Figure 5b) . Moreover, identical results were obtained in the same extracts prevented from activating Plx1 (Figure 5a ). Thus Plx1 is not required to maintain the cyclin degradation pathway switched on if microcystin-sensitive phosphatases are inactivated.
Since Plx1 prevents premature inactivation of the cyclin degradation pathway in the absence of phosphatase inhibitor (Figures 1 and 2 and Table 1), we conclude that Plx1 and an unknown microcystinsensitive phosphatase antagonistically control duration of the window for degradation of mitotic cyclins in the regular cell cycle.
Plx1 does not significantly activate the cyclin degradation pathway in the absence of cyclin B-cdc2 kinase
Phosphorylation of several APC subunits, including cdc27, is required for APC Fizzy activity. MPF-activated Plx1 is not sucient to maintain cdc27 in its hyperphosphorylated form after inactivation of MPF, even though Plx1 does not appear to decline rapidly under such conditions. In the next experiment, we investigated whether Plx1 is able to phosphorylate cdc27 and to activate the cyclin degradation pathway in egg extracts lacking cyclin B-cdc2 kinase. These extracts were prepared after parthenogenetic activation of eggs kept in the absence or in the presence of cycloheximide. This treatment allows suppression of cyclin B neo-synthesis after its Ca 2+ -dependent degradation. As shown in Figure 6 (compare a and b), microcystin readily activated cdc2 and Plx1 kinases, and triggered both cdc27 phosphorylation and cyclin B degradation in the absence of cycloheximide. In contrast however, when microcystin is added to cycloheximide-treated extract, cyclin B-cdc2 kinase activation failed and no signi®cant degradation of [ 35 S]cyclin B could be observed (compare Figure 6c and  d) . In the mean time, we observed only a very limited phosphorylation of cdc27 while Plx1 still underwent extensive activation (Figure 6c,d) .
We conclude that Plx1 is neither necessary nor sucient to turn on the cyclin degradation pathway in egg extracts in the absence of cyclin B-cdc2 kinase.
Discussion
During the budding yeast mitotic cell cycle, two distinct activators of APC/cyclosome: Cdc20 and Hct1, successively activate and maintain the ubiquitin-dependent proteasome pathway turned on. This event is specially remarkable during the metaphase/ anaphase transition to the end of G1 phase.
The APC cdc20 regulator is responsible for degradation of Pds1 while Clb5 together with the cdc14 phosphatase activation controls sister chromatids separation (Shirayama et al., 1999) . APC cdh1 is responsible for degradation of the major mitotic cyclin Clb2 (Visintin et al., 1997; Schwab et al., 1997) , that occurs in the cell cycle not earlier than late anaphase. In the same way, the complex cell cycle of higher Eukaryotes involves two homologs of cdc20 and Hct1. Fizzy and Fizzyrelated homologs function as activators of APC, and bind respectively phosphorylated and dephosphorylated APC. This particular interchange of APC regulatory subunits maintain the APC-dependent ubiquitin pathway turned on from onset of anaphase to late G1 (reviewed in Zachariae, 1999) .
In higher Eukaryotes, degradation of all mitotic cyclins occurs early in mitosis (Huang and Ra, 1999; Clute and Pines, 1999) , and this constitutes a major Figure 6 Plx1 does not activate the cyclin degradation pathway in the absence of cyclin B-cdc2 kinase. Two interphase extracts prepared from eggs allowed to translate proteins after parthenogenetic activation (7cycloheximide) or prevented to translate proteins (+cycloheximide) were prepared in parallel from the same batch of unfertilized eggs (see Materials and methods). At zero time, they received microcystin (+microcystin) or not (7microcystin). Aliquots were taken at the indicated times and monitored for: degradation of [ 35 S]cyclin-B1 added at zero time (upper panels); H1 histone kinase activity of homogenates (second panels from the top); kinase activity (a casein as substrate) of Plx1 immunoprecipitates (third panel from the top; results were quanti®ed by liquid scintillation counting); changes of cdc27 electrophoretic mobility by Western blot (bottom panels) dierence with the cell cycle of budding yeast. Homologs of cdc14 do exist in animal cells (Li et al., 1997) and dephosphorylation is required for both binding to APC of the human homolog of Fizzyrelated and for stabilization of the cdk inhibitor p27 kip1 . Thus the mechanism by which cells switch between the two states of active APC may well be conserved in the eukaryotic cell cycle.
In budding yeast, mutants of the Plx1 homolog gene cdc5 are still able to degrade Pds1 and Clb5, but fail to activate cdc14 and to degrade Clb2 (Shirayama et al., 1998) . For this reason, cdc5 is believed to be involved in the switch from APC cdc20 to APC hct1 . In higher Eukaryotes however, a dierent role has been proposed for cdc5 homologs. Human Plk1, for example, has been proposed to stimulate and possibly to be required for APC Fizzy -dependent ubiquitinylation of cyclin B (Kotani et al., 1998) .
A few reports have also examined the possible role of polo-like kinase in the control of APC activity in meiosis of higher Eukaryotes. In Drosophila, hypomorphic polo mutants have no defect in degradation of cyclin B in spermatogenesis, and the earliest defects during the meiotic divisions are a failure to form the correct midzone and mid-body structures at telophase (Carmena et al., 1998) . In Xenopus oocytes, Ca 2+ -dependent release from arrest at second meiotic metaphase was demonstrated to require Plx1 in cell-free extracts, and we showed in the present study that Plx1 controls this step downstream of CaMK II activation. Surprisingly, however, a constitutively active mutant of plx1 was also reported to slow down Ca 2+ -induced degradation of mitotic cyclins in the same meiotic egg extracts (Qian et al., 1999) , indicating that polo kinases may control APC in a rather complex way at meiosis.
The aim of the present study was to examine, beyond Ca 2+ -dependent resumption of meiosis, the possible role of Plx1 in the control of cyclin degradation during the early mitotic cell cycle. We found that Plx1 activity is dispensable for MPF to turn on the cyclin degradation machinery. However, it is required to prevent premature inactivation of the APCdependent proteolytic pathway. At ®rst sight, this is similar to the reported role of cdc5 in budding yeast, where initial activation of APC cdc20 does not require cdc5, whose function is in contrast required to maintain APC activity beyond onset of anaphase.
However, Fizzy-related/Hct1 is not expressed during the early embryonic cell cycle (Sigrist and Lehner, 1997; Lorca et al., 1998) , as proposed for cdc5 in budding yeast. It may be worth emphasizing that even in budding yeast, a possible role of cdc5 in preventing premature inactivation of APC cdc20 has not been ruled out.
When APC cdc20 inactivates exactly when anaphase has not been determined; cdc20 is still detected in cells that have separated their sister chromatids to opposite spindle poles of the cells (Shirayama et al., 1998) , and Hct1 is not reported to bind APC before late anaphase. Interestingly, cells lacking cdc5 fail to move chromatids to opposite spindle poles of the cell. Thus, cdc5 may perhaps maintain APC cdc20 activity during at least part of anaphase in budding yeast too, as it does in the embryonic cell cycle of higher Eukaryotes.
Maintaining the activity of APC Fizzy after degradation of mitotic cyclins, that occurs to a dramatic extent before onset of anaphase in higher Eukaryotes (Huang and Ra, 1999; Clute and Pines, 1999) may be essential to allow late degradation of mitotic substrates, especially in cells that do not express any other APC activator besides Fizzy. Such late APC substrates include CENP-E, a kinesin-like protein that binds to kinetochores early in mitosis, and is degraded in late mitosis (Brown et al., 1996) . PRC1, an homolog of the budding yeast anaphase spindle elongation factor Ase1, that undergoes APC-dependent proteolysis, also has a high level at G2/M that drops dramatically when cells exit mitosis (Jiang et al., 1998) . Interestingly, CENP-E, PRC-1, and a series of other proteins involved in late mitotic events, including the Cdc20-associated Aurora/ Aik/Ipl1 kinase (Gopalan et al., 1997; Schumacher et al., 1998; Farrugio et al., 1999) redistribute to the mitotic spindle midzone and/or midbody where they colocalize with Polo-like kinases. This colocalization may be important to allow late degradation of APC substrates.
Although the mechanism that allows Plx1 to prevent premature inactivation of the APC-dependent proteolytic pathway was not analysed in the present study, we were able to show that microcystin suppresses both the requirement for Plx1 in Ca 2+ -dependent exit from meiosis and the premature APC Fizzy inactivation in the early mitotic cell cycle.
Moreover, as Plx1 is no longer required when microcystin is used in our experiments, we propose that Plx1 could inactivate a microcystin-sensitive phosphatase whose substrate (termed X) should be necessarily phosphorylated in order to allow APC Fizzy activation. Thus, when Plx1 has been previously inactivated, the key substrate X is dephosphorylated by the antagonistic microcystin-sensitive phosphatase. Then the microcystin is able to trigger cyclin B degradation. On the other hand, the later observation of the Figure 6d shows that microcystin is unable to trigger cyclin B degradation in the absence of active cyclin B-cdc2 kinase.
Altogether these results suggest that Plx1 could play a role in the inhibition of an as yet unidenti®ed microcystin and okadaic acid-sensitive phosphatase (perhaps by its direct phosphorylation) while the antagonistic kinase must involve directly or indirectly active cyclin B-cdc2 kinase. Interestingly, an APCinteracting phosphatase sensitive to these potent phosphatase inhibitors has been identi®ed in Xenopus and other higher Eukaryotes (Ollendorf and Donoghue, 1997; Das et al., 1997) . It will be of interest to analyse its possible antagonism with Plx1 in the control of APC Fizzy activity.
Materials and methods

Production of recombinant proteins and immunological procedures
The recombinant GST-X-Mad2 protein (Lorca et al., 1998) and Star®sh cyclin B-cdc2 kinase (LabbeÂ et al., 1989) were prepared as previously described. N-terminally His6-tagged wild-type Plx1 and Plx1 N172A mutant were generous gifts of P Descombes (University of Geneva, Switzerland) and EA Nigg (Max Planck Institute, Munich, Germany). The human cyclin B as well as the constitutive type II calmodulindependent protein kinase mutant were 35 S-methionine-labeled by in vitro translation as described in Lorca et al. (1993) . Anity-puri®ed antibodies against Xenopus Fizzy (X-Fzy), cdc27 (Lorca et al., 1998) as well as star®sh cyclin B, human cyclin A (Lorca et al., 1992) or Xenopus cdc2 C-terminus (Abrieu et al., 1997) have been described elsewhere.
Xenopus egg extracts CSF extracts (Figures 3 and 4) were prepared from unfertilized Xenopus eggs as described by Lorca et al. (1991b) . Interphase extracts (Figures 1, 2 , 5 and 6 and Table 1) were prepared as described previously (Lorca et al., 1998) .
Interphase as well as cycloheximide-treated interphase extracts used in Figure 6 were prepared from dejellied unfertilized eggs transferred in MMR/4 (25 mM NaCl, 0.5 mM KCl, 0.25 mM MgCl 2 , 0.025 mM Na EGTA, 1.25 mM HEPES-NaOH pH 7.7) supplemented or not with cycloheximide (100 mg/ml). Extracts were prepared 40 min after ionophore addition by the same procedure as described for CSF extracts except that cycloheximide (20 mg/ml) was present throughout the procedure when needed.
In vitro degradation assays, immunoprecipitations, immunoblotting and kinase assays
To monitor the phosphorylation gel-shift of cdc27 as well as the degradation of 35 S-labeled star®sh cyclin B, or human cyclin B and cyclin A, samples taken at the indicated times were resolved by SDS ± PAGE and the proteins detected by autoradiography or immunoblotting experiments (ECL system; Amersham-Pharmacia). Plx1 immunodepletions of the extracts were performed as previously described (Abrieu et al., 1998) . H1-kinase activities and Plx1 a casein-kinase activities were performed after immunoprecipitation (Abrieu et al., 1997 (Abrieu et al., , 1998 
